Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
- PMID: 37715082
- PMCID: PMC10673792
- DOI: 10.1007/s40487-023-00244-5
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
Keywords: ADC; ASCO; Cervical cancer; Endometrial cancer; Gynecology cancer; Immunotherapy; Ovarian cancer.
Conflict of interest statement
Kamal S Saini reports consulting fees from the European Commission, and stock and/or other ownership interests in Labcorp Inc., Fortrea Inc., and Quantum Health Analytics (UK) Ltd., outside the submitted work. The other authors do not report any conflicts of interest.
References
-
- The American Cancer society medical and editorial content team. Survival Rates for Ovarian Cancer. Americal cancer Society. Last Revised: Mar 1, 2023 [cited 2023 Aug 3]. Available from: https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-s...
-
- The American Cancer society medical and editorial content team. Survival Rates for Endometrial Cancer. Americal cancer Society. Last Revised: Mar 1, 2023 [cited 2023 Aug 3]. Available from: https://www.cancer.org/cancer/types/endometrial-cancer/detection-diagnos...
-
- The American Cancer society medical and editorial content team. Survival Rates for Endometrial Cancer. Americal cancer Society. Last Revised: Mar 1, 2023 [cited 2023 Aug 3]. Available from: https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-...
Publication types
LinkOut - more resources
Full Text Sources
